New shot therapy aims to stop stimulant psychosis from becoming schizophrenia
NCT ID NCT03485417
First seen Nov 15, 2025 · Last updated May 23, 2026 · Updated 22 times
Summary
This study tested whether long-acting injectable medications (aripiprazole and paliperidone) can better manage psychosis in people who use stimulants compared to standard care. 165 participants in Hong Kong received either the study drugs or usual treatment. The goal was to see if these shots could reduce psychotic symptoms and prevent the condition from turning into schizophrenia.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA AND RELATED DISORDERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Queen Mary Hospital
Hong Kong, 000000, Hong Kong
Conditions
Explore the condition pages connected to this study.